Author(s)' Reply: Is MYCN Overexpression Associated With Poor Outcome in MYCN Non-Amplified Neuroblastomas?

IF 1.3 4区医学 Q3 PATHOLOGY Pediatric and Developmental Pathology Pub Date : 2024-05-01 Epub Date: 2024-02-15 DOI:10.1177/10935266231221898

Manli Zhao, Yan Shu, Weizhong Gu, Hongfeng Tang, Jianhua Mao

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

作者回复：MYCN过表达与MYCN非扩增神经母细胞瘤的不良预后有关吗？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Pediatric and Developmental Pathology 医学-病理学

CiteScore

3.70

自引率

5.30%

发文量

审稿时长

6-12 weeks

期刊介绍： The Journal covers the spectrum of disorders of early development (including embryology, placentology, and teratology), gestational and perinatal diseases, and all diseases of childhood. Studies may be in any field of experimental, anatomic, or clinical pathology, including molecular pathology. Case reports are published only if they provide new insights into disease mechanisms or new information.

期刊最新文献

A Rare Case of an Infant With TFE3 Mutation Presenting With Direct Hyperbilirubinemia and Hepatomegaly. Whole Slide Imaging, Artificial Intelligence, and Machine Learning in Pediatric and Perinatal Pathology: Current Status and Future Directions. Occurrence of Eosinophilic Granulocytes in the Decidua of Placentas With Perinatal Clinical Findings. CD163 Expression in Chronic Intervillositis of Unknown Etiology and SARS-CoV-2 Placentitis. Cord Hemangioma Versus Angiomyxoma: How Many Angels Can Dance on the Head of a Pin?